Picture of SymBio Pharmaceuticals logo

4582 — SymBio Pharmaceuticals News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: SymBio Pharmaceuticals - 9-MTH parent results

Nov 10 (Reuters)-  
             SymBio Pharmaceuticals Limited  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to   
                Sep 30, 2017        Sep 30, 2016      Dec 31, 2017   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales             2.42                1.41              3.58       
                 (+71.7 pct)         (+5.6 pct)        (+51.3 pct)   
  Operating       loss 3.51           loss 1.53         loss 3.93    
  Recurring       loss 3.55           loss 1.92         loss 4.01    
  Net             loss 3.55           loss 1.92         loss 4.01    
  EPS          loss 72.64 yen      loss 51.61 yen    loss 82.16 yen  
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
   
  NOTE - SymBio Pharmaceuticals Limited.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on SymBio Pharmaceuticals

See all news